Abstract
Antimalarial drug resistance has been an obstacle in the fight against malaria over the years. Antimalarial self-medication is one of the factors associated with antimalarial resistance, and is on the rise globally and has become quite common among developing populations. Self-medication is when individuals choose and use medications to treat symptoms they perceive or diagnose themselves, without the guidance of a healthcare professional. This study aimed at investigating prevalence and determinants of antimalarial drug self-medication among adults in Ndola district, Zambia. A cross-sectional study was conducted among adults in Ndola district, Zambia in June 2023. Using multistage cluster sampling, 446 participants were randomly selected and interviewed through a mobile-based structured questionnaire administered by the researchers using Kobo collect/kobo toolbox. The head of household was the primary participant. Data was then exported to Microsoft Excel, cleaned and coded, and thereafter exported to STATA version 16.1 for analysis. Chi-square tests and logistic regression analysis was used to test associations between categorical variables and to estimate the odds of antimalarial drug self-medication associated with the explanatory variables. The prevalence of antimalarial drug self-medication was 20% in this study population and the factors significantly associated were; moderate to mild illness, bad experience with hospital care, lack of knowledge about antimalarial drug resistance, and the perception that antimalarial drug self-medication was not risky. The finding that antimalarial self-medication was common in this study population is suggestive of a poor state of the health-care delivery system possibly due to inadequate manpower, stock out of drugs in health facilities, and lack of awareness about the risks of self-medication. This further suggests that there is great need for regulatory authorities to strengthen drug regulations and update the list of over-the-counter and essential medicines to ensure the safety of public health. In addition, authorities should repackage malaria sensitization messages to strongly highlight the risks of antimalarial drug self-medication.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was not funded by any organisation. All costs were covered by the corresponding author.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was sought and granted from the University of Zambia Biomedical Research Ethics Committee (UNZABREC) REF. No. 3603-2023, and the National Health Research Authority (NHRA) Ref No. NHRA015/03/07/2023. Permission to conduct the study was also sought and granted from Ndola District Health Office. Detailed study information sheets were availed to the participants prior to obtaining informed consent. Participants were allowed to withdraw from the study at any point during the interview and no individual was coerced to participate in the study. Permission was obtained from the head of the household even when he/she would not be the primary respondent. The study maintained the highest level of confidentiality as participants were identified by identification numbers rather than their names nor other personal information.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
A data set and do file used for analysis is readily available and we have no problems availing it whenever necessary
